Liv. 52 studies in acute hepatitis.

Of 250 cases of acute hepatitis studied and followed for 1 year, half were given Liv.52 and the other half either steroid therapy or placebo. The efficacy of the drug with regard to clinical, biochemical and pathological improvement is discussed. Liv.52 restored the liver functions earlier without any side effects. INTRODUCTION The incidence of acute hepatitis in the Institute of Child Health and Hospital for Children, Egmore, Madras-8 is nearly 250 cases per year. Some of them go into complications like acute liver cell failure and a few advance to cirrhosis liver. Drug trial with *Liv.52 was undertaken with a view to study the efficacy of the drug in acute hepatitis in comparison to steroid therapy and placebo. * Liv.52 is a combination of indigenous drugs said to be widely used in cases of liver diseases. It contains: Capparis spinosa 65 mg Cichorium intybus 65 mg Solanum nigrum 32 mg Cassia occidentalis 16 mg Terminalia arjuna 32 mg Achillea millefolium 16 mg Tamarix gannlliea 16 mg Mandur bhasma 33 mg